134 related articles for article (PubMed ID: 175770)
1. Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship.
Rapin I; Suzuki K; Suzuki K; Valsamis MP
Arch Neurol; 1976 Feb; 33(2):120-30. PubMed ID: 175770
[TBL] [Abstract][Full Text] [Related]
2. GM2-gangliosidosis, AB variant: clinico-pathological study of a case.
de Baecque CM; Suzuki K; Rapin I; Johnson AB; Whethers DL
Acta Neuropathol; 1975 Dec; 33(3):207-26. PubMed ID: 174379
[TBL] [Abstract][Full Text] [Related]
3. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.
Kotagal S; Wenger DA; Alcala H; Gomez C; Horenstein S
Neurology; 1986 Mar; 36(3):438-40. PubMed ID: 3081832
[TBL] [Abstract][Full Text] [Related]
4. The gangliosidoses.
Volk BW; Adachi M; Schneck L
Hum Pathol; 1975 Sep; 6(5):555-69. PubMed ID: 170187
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.
Paw BH; Kaback MM; Neufeld EF
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660
[TBL] [Abstract][Full Text] [Related]
6. The clinical aspects of adult hexosaminidase deficiencies.
Federico A; Palmeri S; Malandrini A; Fabrizi G; Mondelli M; Guazzi GC
Dev Neurosci; 1991; 13(4-5):280-7. PubMed ID: 1840098
[TBL] [Abstract][Full Text] [Related]
7. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis.
Meek D; Wolfe LS; Andermann E; Andermann F
Ann Neurol; 1984 Apr; 15(4):348-52. PubMed ID: 6430210
[TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical heterogeneity of adult GM2 gangliosidosis.
Navon R
Dev Neurosci; 1991; 13(4-5):295-8. PubMed ID: 1840100
[TBL] [Abstract][Full Text] [Related]
9. Morphology of the gangliosidoses.
Goebel HH
Neuropediatrics; 1984 Sep; 15 Suppl():97-106. PubMed ID: 6100800
[TBL] [Abstract][Full Text] [Related]
10. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
[TBL] [Abstract][Full Text] [Related]
11. Animal model of human disease: GM2 gangliosidosis.
Pierce KR; Kosanke SD; Bay WW; Bridges CH
Am J Pathol; 1976 May; 83(2):419-22. PubMed ID: 817606
[No Abstract] [Full Text] [Related]
12. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Conzelmann E; Sandhoff K
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.
Martin DR; Cox NR; Morrison NE; Kennamer DM; Peck SL; Dodson AN; Gentry AS; Griffin B; Rolsma MD; Baker HJ
Acta Neuropathol; 2005 Nov; 110(5):443-50. PubMed ID: 16200419
[TBL] [Abstract][Full Text] [Related]
14. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
[TBL] [Abstract][Full Text] [Related]
15. [The so-called amaurotic idiocies. Clinical, morphological and biochemical findings as a basis for modern classification].
Minauf M
Veroff Pathol; 1975; 96():1-89. PubMed ID: 180723
[TBL] [Abstract][Full Text] [Related]
16. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect.
Navon R; Kolodny EH; Mitsumoto H; Thomas GH; Proia RL
Am J Hum Genet; 1990 Apr; 46(4):817-21. PubMed ID: 2278539
[TBL] [Abstract][Full Text] [Related]
17. Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay.
Molzer B; Bernheimer H
Clin Chim Acta; 1976 Nov; 73(1):163-9. PubMed ID: 826357
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
20. The AB-variant of GM2-gangliosidosis. Clinical, biochemical, and pathological studies of two patients.
Goldman JE; Yamanaka T; Rapin I; Adachi M; Suzuki K; Suzuki K
Acta Neuropathol; 1980; 52(3):189-202. PubMed ID: 6255724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
